Wikidata

(Q64172978)

English

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)

clinical trial

In more languages

Statements

short name
focuSSced (English)
0 references
title
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Italy
0 references
Japan
0 references
Lithuania
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
South Africa
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
20 November 2015
0 references
end time
15 January 2018
0 references
number of participants
212
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64172978&oldid=1857592701"